Retrospective analysis of 27 consecutive patients treated with docetaxel/nedaplatin combination therapy as a second-line regimen for advanced esophageal cancer

International Journal of Clinical Oncology

Volumn 12, Issue 3, 2007, Pages 224-227

  Kanai, Masashi ^a   Matsumoto, Shigemi ^a   Nishimura, Takahumi ^a   Shimada, Yutaka ^a   Watanabe, Go ^a   Kitano, Toshiyuki ^a   Misawa, Akiko ^a   Ishiguro, Hiroshi ^a   Yoshikawa, Kiyotsugu ^a   Yanagihara, Kazuhiro ^a   Teramukai, Satoshi ^a   Mitsumori, Michihide ^a   Chiba, Tsutomu ^a   Sakai, Yoshiharu ^a   Fukushima, Masanori ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Chemotherapy; Docetaxel; Esophageal cancer; Nedaplatin

Indexed keywords

DOCETAXEL; NEDAPLATIN;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ANOREXIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; LEUKOPENIA; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OUTCOME ASSESSMENT; OUTPATIENT CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSORY NEUROPATHY; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG TOXICITY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL ANALYSIS; TAXOIDS;

EID: 34250672434     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-007-0666-x     Document Type: Article

References (17)

1. Greenlee RT, Hill-Harmon MB, Murray T, et al. (2001) Cancer statistics. CA Cancer J Clin 51:15-36. Erratum in: CA Cancer J Clin 2001 Mar-Apr; 51:144
2. Foundation for promotion of cancer Research 2001 Cancer Statistics in Japan Editorial Board Japanese National Cancer Center Tokyo
3. PC Enzinger DH Ilson DP Kelsen 1999 Chemotherapy in esophageal cancer (review) Semin Oncol 26 5 Suppl 15 12 20
4. JA Ajani DH Ilson K Daugherty 1994 Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus J Natl Cancer Inst 86 1086 1091
5. DH Ilson L Saltz P Enzinger 1999 Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer J Clin Oncol 17 3270 3275
6. T Conroy PL Etienne A Adenis 2002 European Organisation for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival Ann Oncol 13 721 729
7. K Hayashi N Ando H Watanabe 2001 Phase II evaluation of protracted infusion of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG) Trial (JCOG9407) Jpn J Clin Oncol 31 419 423
8. ME Trudeau 1996 Docetaxel: a review of its pharmacology and clinical activity Can J Oncol 6 443 457
9. K Muro T Hamaguchi A Ohtsu 2004 A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer Ann Oncol 15 955 959
10. J Metges C Hennequin M Ychou 2001 Docetaxel as a second line chemotherapy in metastatic esophageal cancer: a French study Proc Am Soc Clin Oncol 20 160a Abstr 635
11. Y Sasaki T Shinkai K Eguchi 1991 Prediction of the antitumor activity of new platinum analogs based on their ex vivo pharmacodynamics as determined by bioassay Cancer Chemother Pharmacol 27 263 270
12. DS Alberts PT Fanta KL Ruuing 1997 In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers Cancer Chemother Pharmacol 39 493 497
13. T Kurata K Tamura N Yamamoto 2004 Combination phase I study of nedaplatin and gemcitabine for advanced non-small-cell lung cancer Br J Cancer 90 2092 2096
14. H Kurita E Yamamoto S Nozaki 2004 Multicenter phase I trial of induction chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinoma Oral Oncol 40 1000 1006
15. P Therasse SG Arbuck EA Eisenhauer 2000 New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 205 216
16. Y Osaka Y Takagi S Hoshino 2006 Combination chemotherapy with docetaxel and nedaplatin for recurrent esophageal cancer in an outpatient setting Dis Esophagus 19 473 476
17. Abe T, et al. (2005) A phase I trial of docetaxel/nedaplatin combination therapy for advanced esophageal cancer. The 59th Annual Meeting of the Japan Esophageal Society, Tokyo, June 2005